Suchergebnisse - "Daratumumab"

PubPharm (242)

1

Four-Drug Therapy for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sampath, V.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

2

Four-Drug Therapy for Multiple Myeloma. Reply

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

3

Extramedullary relapse of multiple myeloma presenting as space-occupying lesion in liver treated with daratumumab, pomalidomide, dexamethasone and bendamustine

enthalten in: BMJ case reports | 2024

von Wadhera, S. | Jain, A. | Mitra, S. | +1

4

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

5

Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma

enthalten in: European journal of haematology | 2024

von Dima, D. | Mansour, R. | Davis, J. | +9

6

ANCHOR : melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study

enthalten in: Haematologica | 2024

von Ocio, E. | Efebera, Y. | Hájek, R. | +12

7

Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma : results from the randomized, open-label, phase III LIGHTHOUSE study

enthalten in: Haematologica | 2024

von Pour, L. | Szarejko, M. | Bila, J. | +13

8

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma : an indirect treatment comparison

enthalten in: Leukemia & lymphoma | 2024

von Weisel, K. | Dimopoulos, M. | Beksac, M. | +7

9

Analysis of efficacy and safety of daratumumab-containing regimen in relapsed and refractory multiple myeloma patients

enthalten in: Zhonghua yi xue za zhi | 2024

von Yu, Q. | Zhou, X. | Wu, H. | +3

10

Daratumumab in Indian patients with relapsed and refractory multiple myeloma : a prospective, multicenter, phase IV study

enthalten in: Future oncology (London, England) | 2024

von Kumar, L. | Melinkeri, S. | Ganesan, P. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]